Lumos Pharma Inc
LUMO
Get informed when a big investor buys or sells
+ FollowMarket Cap$37.54M
Close$
$14.16
226.2% upside
Current Fair Value
226.2% upsideUndervalued by 226.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $37.54 Million |
|---|---|
| Enterprise Value | $24.15 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-4.18 |
| Beta | 0.33 |
| Outstanding Shares | 8,327,488 |
Return
| Return on Equity | -710.54% |
|---|---|
| Return on Assets | -199.97% |
| Return on Invested Capital | -331.59% |
Valuation & Multiples
| P/E Ratio | -1.04 |
|---|---|
| PEG | 10.35 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 10.95 |
| Enterprise Value to EBIT | -0.66 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.03 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data